Recruiting

Observational Study

Sponsor:

Massachusetts General Hospital

Code:

NCT05966038

Conditions

ALS

PLS

MND (Motor Neurone DIsease)

Kennedy Disease

PMA - Progressive Muscular Atrophy

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

This is a data repository for multi-site multi-protocol clinic-based Natural History Study of ALS and Other Motor Neuron Disorders (MND).

All people living with ALS or other MNDs who attend clinics at the Study hospitals (sites) are offered to participate in the Study.

The Sites collect so-called Baseline information including demographics, disease history and diagnosis, family history, etc. At each visit, the Sites also collect multiple disease-specific outcome measures and events. The information is captured in NeuroBANK, a patient-centric clinical research platform.

The Sites have an option to choose to collect data into 20+ additional forms capturing biomarkers and outcome measures. Captured data after its curation are anonymized (all personal identifiers and dates are being removed), and the anonymized dataset is shared with medical researchers via a non-exclusive revocable license.

Funding Source - Biogen, Inc.; Mitsubishi Tanabe Pharma America; FDA OOPD.

Conditions

ALS

PLS

MND (Motor Neurone DIsease)

Kennedy Disease

PMA - Progressive Muscular Atrophy

Study ID

NCT05966038

Start date

Apr 1, 2015

Status verified date

May, 2026

Completion date

Dec 31, 2030

Anticipated

Primary completion date

Dec 31, 2030

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • A clinical diagnosis of El Escorial of suspected, possible, probable, or definite ALS or
  • Other motor neuron disorders, including but not limited to Spinal-Bulbar Muscular Atrophy (SBMA, Kennedy's disease), Spinal Muscular Atrophy (SMA), Primary Lateral Sclerosis (PLS), Progressive Muscular Atrophy (PMA), and Progressive Bulbar Palsy (PBP)

Exclusion Criteria:

  • Disease does not meet criteria for any motor neuron disorder

Study Design

Enrollment

5000 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • ALS Functional Rating Scale-Revised (ALSFRS-R) [ Time Frame: Every 3-4 months up to 5 years ]
  • Slow Vital Capacity (SVC) [ Time Frame: Every 3-4 months up to 5 years ]
  • Survival [ Time Frame: Every 3-4 months up to 5 years ]

Central Contacts and Locations

Central contacts

Locations

Loma Linda University Health

Recruiting

Loma Linda, California, United States, 92354

Principal Investigator:

Jeffrey Rosenfeld, MD

Kaiser Permanente

Recruiting

Los Angeles, California, United States, 90027

Contacts

Principal Investigator:

Abel Wu, MD

University of Florida

Recruiting

Gainesville, Florida, United States, 32610

Contacts

Principal Investigator:

James Wymer

Northwestern University

Recruiting

Chicago, Illinois, United States, 60611

Contacts

Principal Investigator:

Senda Ajroud-Driss

Lahey Clinic

Recruiting

Burlington, Massachusetts, United States, 01805

Contacts

Principal Investigator:

Medhi Ghasemi, MD

Henry Ford Health System

Recruiting

Detroit, Michigan, United States, 48202

Contacts

Principal Investigator:

Ximena Arcila Londono

Trinity Health Michigan

Recruiting

Grand Rapids, Michigan, United States, 49503

Contacts

Principal Investigator:

Melanie G Taylor, MD

University of Minnesota

Recruiting

Minneapolis, Minnesota, United States, 55455

Contacts

Principal Investigator:

David Walk

Saint Louis University

Recruiting

St Louis, Missouri, United States, 63104

Contacts

Principal Investigator:

Ghazala Hayat

Providence ALS Clinic

Recruiting

Portland, Oregon, United States, 97213

Contacts

Principal Investigator:

Nicholas Olney

Thomas Jefferson University

Recruiting

Philadelphia, Pennsylvania, United States, 19107

Contacts

Principal Investigator:

Hristelina Ilieva, MD

Temple University Lewis Katz School of Medicine

Recruiting

Philadelphia, Pennsylvania, United States, 19140

Contacts

Principal Investigator:

Terry Heiman-Patterson

University of Pittsburgh

Recruiting

Pittsburgh, Pennsylvania, United States, 15360

Contacts

Principal Investigator:

Tawfiq Al-lahham, MD

Virginia Commonwealth University

Recruiting

Richmond, Virginia, United States, 22908

Contacts

Principal Investigator:

Kelly Gwathmey

More Information

Sponsor

Massachusetts General Hospital

Last update posted

May 20, 2026

Last verified

May, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-04. This information was provided to ClinicalTrials.gov by Massachusetts General Hospital on 2026-05-20.